All In MedTech

Device Trial Radar · NCT02912507

Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal

An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal

Last checked: Nov 20, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

11

Actual

Start

Sep 9, 2016

Primary completion

Aug 16, 2017

Study completion Aug 16, 2017

Sponsor

Lead sponsor
Cutera Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 23, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser

Conditions

  • Tattoo Removal

Interventions

  • Cutera enlighten laserDevice

    high-powered, Q-switched 670nm Picosecond laser system indicated for tattoo removal

  • CynoSure PicoSure 755nm laserDevice

    high-powered, Q-switched Alexandrite system that delivers laser energy in the 755 nm wavelength and has received FDA clearance (K133364) for tattoo and benign pigmented lesion removal.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Degree of Tattoo Clearing as Assessed by the Investigator (Physician's Global Assessment of Improvement)Time frame: 6 weeks post-final treatment, an average of 8 months from baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Laser Skin Solutions Jacksonville

    Jacksonville Beach, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.